Search Results 2551-2560 of 20368 for menopause
Ibandronate is used to treat and prevent osteoporosis (thinning of the bone) in women after menopause. This medicine is available only with your doctor's ...
Participant is not pregnant, lactating, or of childbearing potential (i.e., women must be two years post-menopausal or surgically sterile). Willing and able ...
Females of childbearing potential are defined as premenopausal and not surgically sterilized, or post-menopausal for fewer than 2 years. A urine pregnancy ...
Sexual dysfunction, Breast cancer, Menopause, Vaginal atrophy, Perimenopause, Breast cysts and lumps, Breast pain. Research. Doctors discussing imaging test ...
Areas of focus: Sexual dysfunction, Breast cancer, Menopause, Vaginal atrophy, Perimenopause, Breast cysts and lumps, Breast pain. Research. Doctors ...
Osteoporosis, Breast cancer, Menopause, BRCA gene mutation. Timothy J. Hobday, M.D.. Oncologist. Rochester, MN. Areas of focus ...
Kok, M.D.. Internist. Rochester, MN. Areas of focus: Sexual dysfunction, Breast cancer, Menopause, Vaginal atrophy, Perimenopause, Breast cysts and lumps, ...
Women are considered post-menopausal and not of child bearing potential if they have had 12 months of natural (spontaneous) amenorrhea with an appropriate ...
Alternatively, female subjects must be of non-reproductive potential (i.e., post-menopausal by history: ≥ 60 years old and no menses for ≥ 1 year without ...
... Menopause-related conditions. Show more areas of focus for Aakriti R. Carrubba, M.D.. Stephen D. Cassivi, M.D., M.S.. Thoracic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.